BIOTRICITY INC.
Close on Oct 19, 2026
- Market cap
- $1.15M
- P/E (TTM)
- –
- Dividend yield
- –
About Biotricity
Surgical & Medical Instruments & Apparatus, SIC 3841
Biotricity Inc. is a medical technology company that provides biometric data monitoring and remote patient monitoring solutions focused on diagnostic and chronic care management. The company primarily targets the ambulatory cardiac outpatient monitoring market, developing products for both clinical and consumer use. Its clinical technologies include the Bioflux mobile cardiac outpatient monitoring system and the Biocore three-lead cardiac monitoring device line, featuring the cellular Biocore Pro patch for electrocardiogram and arrhythmia detection. For consumers, Biotricity offers the Bioheart continuous heart monitor, alongside chronic disease platforms such as Biokit and Biocare. The company sells its diagnostic devices and recurring utilization-based monitoring services to clinics, physicians' offices, hospitals, and independent diagnostic testing facilities.
The company operates across thirty-five states in the United States, utilizing an insourcing business model to supply medical facilities. Biotricity is incorporated in the state of Nevada. It maintains its principal executive offices in Redwood City, California, and also lists headquarters in Nevada and Toronto, Ontario, Canada.
Summary of the business section of Biotricity's latest annual report, written by StockData.
Company profile
Company
- Legal name
- BIOTRICITY INC.
- Headquarters
- Redwood City, CA
- Address
- 203 Redwood Parkway, Suite 600 94065
- Phone
- (800) 590-4155
- Website
- biotricity.com
- Employees
- 46, Mar 31, 2026
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- Nevada
- Fiscal year ends
- March 31
- Auditor
- SRCO Professional Corporation, Richmond Hill, Ontario, Canada
Stock & identifiers
- Ticker
- BTCY
- Exchange
- OTC
- IPO date
- Feb 19, 2016
- Shares outstanding
- 20M, Aug 19, 2026
- Public float
- $13.50M, Sep 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-6 reverse, Nov 14, 2023; 1-for-6 reverse, Jul 3, 2023
- SEC CIK
- 1630113
- CUSIP
- 09074H203
- ISIN
- US09074H2031
- LEI
- 5493000L48S51ZYDK260
- EIN
- 47-2548273
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
Biotricity's leadership is listed in its proxy statement, last filed Aug 5, 2024.
Employees
Headcount reported in annual reports
“We currently have 46 full-time employees and approximately 20 consultants who are based in our offices located in Silicon Valley, California and Toronto, Canada.”
Corporate history
Events identified from SEC filings